Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 21.1M 19.67M 17.83M 33.56M 2.24B 33.83M 236M 92.25M 1.17B 88.73M 86.78M 3.74B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 37.68M 35.12M 31.84M 59.93M 4B 60.4M 421M 165M 2.08B 158M 155M 6.68B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
04/08/17 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
15/05/17 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
13/02/17 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
13/11/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
04/10/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/05/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/02/16 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/02/16 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/12/15 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/12/15 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
01/12/15 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/11/15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
12/10/15 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 day+4.55%
1 week+4.55%
Current month+4.55%
1 month+9.52%
3 months-34.29%
6 months-68.06%
Current year-30.30%
1 week 0
Extreme 0.0023
0
1 month 0
Extreme 0.0022
0
Current year 0
Extreme 0.0011
0.01
1 year 0
Extreme 0.0011
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 0
0.65
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
+4.55%+4.55%-73.86%+91.67% 877K
+1.06%+2.70%-32.62%-54.11% 1.75B
-1.37%-1.08% - - 1.58B
+0.61%+14.37%-38.44%+26.93% 1.15B
-2.08%+1.11%-36.44%+137.99% 1.14B
+0.09%+4.96%+46.42%+41.85% 984M
-1.27%-8.58%+170.88%+750.25% 878M
-3.18%-0.40%+3.85%+168.05% 744M
-3.88%-1.52%0.00%+46.69% 738M
+2.31%+2.90%+42.38%-34.00% 533M
Average -0.32%+2.68%+9.13%+130.59% 949.62M
Weighted average by Cap. -0.74%+3.17%+9.89%+118.06%

Financials

2015 2016
Net sales 25.48M 22.76M 21.22M 19.24M 36.2M 2.42B 36.48M 254M 99.5M 1.26B 95.7M 93.6M 4.04B 32.33M 28.88M 26.92M 24.4M 45.93M 3.07B 46.29M 322M 126M 1.6B 121M 119M 5.12B
Net income 5.49M 4.91M 4.58M 4.15M 7.81M 522M 7.87M 54.81M 21.46M 271M 20.64M 20.18M 870M 2.06M 1.84M 1.72M 1.56M 2.93M 196M 2.95M 20.56M 8.05M 102M 7.74M 7.57M 327M
Net Debt 24.8M 22.16M 20.65M 18.72M 35.24M 2.35B 35.51M 247M 96.85M 1.22B 93.16M 91.11M 3.93B 18.56M 16.58M 15.45M 14.01M 26.37M 1.76B 26.57M 185M 72.47M 916M 69.7M 68.17M 2.94B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. AOXG Stock